Cargando…

Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study

INTRODUCTION: As the immunosuppressive potency of 15-deoxyspergualin (DSG) has been shown in the therapy of renal transplant rejection and Wegener's granulomatosis, the intention of this study was to evaluate the safety of DSG in the therapy of lupus nephritis (LN). METHODS: Patients with histo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenz, Hanns-Martin, Schmitt, Wilhelm H, Tesar, Vladimir, Müller-Ladner, Ulf, Tarner, Ingo, Hauser, Ingeborg A, Hiepe, Falk, Alexander, Tobias, Woehling, Heike, Nemoto, Kyuichi, Heinzel, Peter A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132014/ https://www.ncbi.nlm.nih.gov/pubmed/21356124 http://dx.doi.org/10.1186/ar3268

Ejemplares similares

The immunosuppressant 15-deoxyspergualin [correction of 1,5- deoxyspergualin] reveals commonality between preT and preB cell differentiation
Publicado: (1996)

Myeloprotective Activity of Deoxyspergualin: Influence on Splenic Colony‐forming Cell Injury and Antitumor Activity of Mitomycin C in Mice
por: Nemoto, Kyuichi, et al.
Publicado: (1992)

Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
por: Ishida, Hideki, et al.
Publicado: (2008)

Cytostatic Effect of Deoxyspergualin on a Murine Leukemia Cell Line L1210
por: Hiratsuka, Masaharu, et al.
Publicado: (1991)

Clinically relevant advances in rheumatoid arthritis therapy
por: Müller-Ladner, Ulf, et al.
Publicado: (2009)

Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!
por: Müller-Ladner, Ulf, et al.
Publicado: (2010)

Low-field magnetic resonance imaging study on carpal arthritis in systemic sclerosis - low-grade erosive arthritis of carpal bones is an unexpected and frequent disease manifestation
por: Akbayrak, Elif, et al.
Publicado: (2013)

Microangiopathy in Inflammatory Diseases—Strategies in Surgery of the Lower Extremity
por: Biehl, Christoph, et al.
Publicado: (2022)

Strongyloides Duodenitis in an Immunosuppressed Patient with Lupus Nephritis
por: Jegadeesan, Ramprasad, et al.
Publicado: (2018)

Evidence for synovial fibroblasts spreading rheumatoid arthritis
por: Müller-Ladner, Ulf, et al.
Publicado: (2012)

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
por: Adler, Sabine, et al.
Publicado: (2018)

Outcomes of Escalating Immunosuppressive Treatments for Recalcitrant Noninfectious Posterior Scleritis
por: Pan, Yuan, et al.
Publicado: (2022)

Cytokine imbalance in NZB/W mice is associated with autoantibody levels and nephritis
por: Enghard, P, et al.
Publicado: (2004)

Overlapping presentation of fungal tubulointerstitial nephritis in an immunosuppressed pediatric patient
por: Tee, James B., et al.
Publicado: (2009)

Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts
por: Neumann, Elena, et al.
Publicado: (2010)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients
por: Zakharova, Elena V., et al.
Publicado: (2016)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Relapse and Outcome of Lupus Nephritis After Renal Transplantation in the Modern Immunosuppressive Era
por: Pattanaik, Debendra, et al.
Publicado: (2022)

Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
por: Hunnicutt, Jacob N., et al.
Publicado: (2023)

Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice
por: Khodadadi, Laleh, et al.
Publicado: (2015)

Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden
por: Flodmark, Carl-Erik, et al.
Publicado: (2013)

Identification and characterization of antigen-specific CD4(+) T cells targeting renally expressed antigens in human lupus nephritis with two independent methods
por: Tesch, Sebastian, et al.
Publicado: (2020)

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts
por: Diller, Magnus, et al.
Publicado: (2019)

Combination of cellular imaging and molecular analysis for evaluation of cellular gene therapy of RA
por: Tarner, IH, et al.
Publicado: (2003)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Collagenous repeat containing sequence of 26 kDa protein: a novel mesenchymal gene of cartilage and adipose tissue differentiation
por: Tarner, IH, et al.
Publicado: (2005)

Novel tools for molecular analysis in synovium
por: Mueller-Ladner, U, et al.
Publicado: (2003)

Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis
por: Singh, Jasvinder A., et al.
Publicado: (2016)

Infective endocarditis in a patient with lupus nephritis who was undergoing immunosuppressive therapy: A case of survival
por: Ihara, Katsuhito, et al.
Publicado: (2017)

Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients
por: Yin, Peihong, et al.
Publicado: (2020)

B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
por: Yap, Desmond Y. H., et al.
Publicado: (2019)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)

Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
por: Molinaro, Antonio, et al.
Publicado: (2017)

Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis
por: Goumenos, Dimitrios S, et al.
Publicado: (2005)

Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis
por: Singh, Jasvinder A., et al.
Publicado: (2016)

Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial
por: Jourde-Chiche, Noemie, et al.
Publicado: (2022)

Adipokines and Inflammation Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts and Endothelial Cells
por: Hasseli, Rebecca, et al.
Publicado: (2020)

Targeting of Janus Kinases Limits Pro-Inflammatory but Also Immunosuppressive Circuits in the Crosstalk between Synovial Fibroblasts and Lymphocytes
por: Yao, Nina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fcc1kq945jmt2tqhpbonbc5cl9